SCHEMBL14985384

SCHEMBL14985384

CN1CC[C@H](CF)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18133745 1.00
SCHEMBL14930347 1.00
SCHEMBL15038030 0.86
SCHEMBL21567214 0.85
SCHEMBL15038033 0.85
SCHEMBL18270978 0.85
SCHEMBL15038032 0.83 CHRM5 (0.38)
SCHEMBL10273035 0.80
SCHEMBL15038034 0.78 NCF1 (0.48)
SCHEMBL12371223 0.78 NCF1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377060-B1 PYRAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF LUNDBECK LA JOLLA RESEARCH CENTER INC (US) 2020-08-19 EP disclosed
WO-2020154683-A1 METHODS OF TREATING DISEASE WITH MAGL INHIBITORS LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2020-07-30 WO disclosed
US-20190256494-A1 PYRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2019-08-22 US disclosed
WO-2016189011-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2016-12-01 WO disclosed
US-20160347742-A1 HETEROCYCLIC ESTROGEN RECEPTOR MODULATORS AND USES THEREOF GENENTECH, INC. (US) 2016-12-01 US disclosed
US-20150258080-A1 THERAPEUTIC COMBINATIONS WITH ESTROGEN RECEPTOR MODULATORS GENENTECH, INC. (US) 2015-09-17 US disclosed
US-8853423-B2 Indane estrogen receptor modulators and uses thereof SERAGON PHARMACEUTICALS, INC. (US) 2014-10-07 US disclosed
US-20130137746-A1 INDANE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF ARAGON PHARMACEUTICALS, INC. (US) 2013-05-30 US disclosed